Dreams within reach: New RED scholars earn two years tuition-free
Cornell University CVM
A veterinary degree from Cornell University may feel financially out of reach for many students; however, the Cornell University College of Veterinary Medicine (CVM) is more affordable than most people think. With over four million dollars in scholarships awarded annually and 65-70% of students receiving scholarship aid, the dream of a Cornell veterinary degree can be an achievable reality. This is true for CVM’s newest cohort of RED (Reducing Educational Debt) scholars.
New faculty profile: Dr. Jan Lovy
Cornell University CVM
The Cornell University College of Veterinary Medicine (CVM) has recently welcomed many new faculty members to our academic departments, each one bringing a unique set of skills and experience that enriches our college every day. In this Q&A series, you’ll get to know their interests, expertise and more. Here is Dr. Jan Lovy, associate professor, Department of Public and Ecosystem Health.
Inaugural AVMF Excellence Award given to Larry, Rita Dee
AVMA
The American Veterinary Medical Foundation (AVMF) is giving its first Excellence Award to the late Dr. Larry Dee and his wife, Rita. He was a member of the Foundation’s development council when he died earlier this year at the age of 83.
Belonging and engagement roundtable unites veterinary affinity groups
AVMA
The AVMA hosted seven affinity and allied groups from across the industry for a belonging and engagement roundtable that sparked discussion, ideas, hope, and a desire for future collaboration. In all, 28 industry leaders and group representatives attended the in-person event, held June 17-18 at AVMA headquarters in Schaumburg, Illinois, which was facilitated by Latonia Craig, EdD, AVMA chief of veterinary engagement and belonging.
FDA unveils 3-year blueprint to expand drug development for minor uses and minor species
DVM360
The FDA’s Center for Veterinary Medicine (CVM) has released itsMUMS Blueprint for Success: 2026-2028, a 3-year strategic plan designed to modernize and grow the agency’s Minor Use and Minor Species (MUMS) program. Announced June 30, 2026, the blueprint lays out future actions and proposals intended to improve access to safe, effective drugs for animal populations that drug sponsors have historically overlooked.
Recent Comments